J&J COVID-19 vaccine under EU review over blood clots leaderpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from leaderpost.com Daily Mail and Mail on Sunday newspapers.
Two of the scientists behind Britain s AstraZeneca jab could both make £26million today as the tech firm that developed it hits the US stock market.
Oxford professors Sarah Gilbert and Adrian Hill both own 5.2 per cent of Vaccitech, which will later float on America s Nasdaq exchange.
The pair are alongside other scientists and investors who put money and expertise into the company after it was founded in 2016.
Companies House papers audited by MailOnline show Profs Gilbert and Hill each hold 2,500 ordinary shares in the firm, out of a total 47,827.
Experts have suggested it is targeting a value of some £509 million, meaning if this is realised, the two scientists stakes will be each worth £26.4million.
Updated safety advisory – rare and unusual blood clotting syndrome (thrombosis with thrombocytopaenia)
To date, one case of thrombosis with thrombocytopenia reported in Australia has been assessed by the Vaccine Safety Investigation Group (VSIG). The VSIG is an independent expert advisory group comprising experts in vaccine safety, public health, vaccine confidence and relevant medical specialists in blood disorders, immunology, gastroenterology, infectious diseases, convened by the TGA to assess such cases. The VSIG concluded that, based on available data, there was insufficient evidence to firmly confirm that the clot was caused by the vaccine, but emerging evidence suggests a likely association. However, this conclusion will be reviewed as further information becomes available.
Government s vaccine advisory group recommended healthy people aged 19 to 29 offered different vaccine
Review by drugs watchdog MHRA found that 79 out of 20m Britons given AZ vaccine suffered blood clots
MHRA insisted there was still no concrete proof vaccine is causing the clots, but admitted link getting firmer
Matt Hancock said it showed the safety system is working because regulators can spot extremely rare event
He said AstraZeneca vaccine is safe and there is more than enough Moderna and Pfizer jabs for under-30s
Health Secretary also insisted Government remains on course to offer all UK adults a jab by the end of July
Covid-19 Ireland latest: NPHET meeting to discuss AstraZeneca blood clots warning as vaccine timeline emerges
It comes as the UK this week moved to stop using the vaccine on people aged under 30 who will instead be offered Pfizer and Moderna vaccines
Updated
The video will auto-play soon8Cancel
Play now
Never miss an update on schools, pubs and coronavirus cases with our free newsletterInvalid EmailSomething went wrong, please try again later.
Sign up!
When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. OurPrivacy Noticeexplains more about how we use your data, and your rights. You can unsubscribe at any time.